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ABSTRACT
DNA methylation plays a critical role in the regulation
and maintenance of cell-type specific transcriptional
programs. Targeted epigenome editing is an emerg-
ing technology to specifically regulate cellular gene
expression in order to modulate cell phenotypes or
dissect the epigenetic mechanisms involved in their
control. In this work, we employed a DNA methyl-
transferase Dnmt3a–Dnmt3L construct fused to the
nuclease-inactivated dCas9 programmable targeting
domain to introduce DNA methylation into the hu-
man genome specifically at the EpCAM, CXCR4 and
TFRC gene promoters. We show that targeting of
these loci with single gRNAs leads to efficient and
widespread methylation of the promoters. Multiplex-
ing of several guide RNAs does not increase the effi-
ciency of methylation. Peaks of targeted methylation
were observed around 25 bp upstream and 40 bp
downstream of the PAM site, while 20–30 bp of the
binding site itself are protected against methylation.
Potent methylation is dependent on the multimeriza-
tion of Dnmt3a/Dnmt3L complexes on the DNA. Fur-
thermore, the introduced methylation causes tran-
scriptional repression of the targeted genes. These
new programmable epigenetic editors allow unprece-
dented control of the DNA methylation status in cells
and will lead to further advances in the understand-
ing of epigenetic signaling.
INTRODUCTION
Epigenetic modifications control cellular gene expression
profiles and maintain the cell’s differentiation state (1,2).
DNA methylation has emerged as a key mechanism gov-
erning cellular reprogramming processes, such as cell dif-
ferentiation, cellular senescence and disease (2). Aberra-
tions in DNA methylation patterns caused by mutations
or mis-regulation of the DNA methylation machinery are
commonly found in cancer cells and contribute to car-
cinogenesis (2,3). In mammalian cells, DNA methylation
is abundantly found in the context of CpG dinucleotides
and methylation of CpG-rich promoter regions is cor-
related with their transcriptional repression (1,4). DNA
methylation patterns are established by the de novo DNA
methyltransferases Dnmt3a and Dnmt3b, the activity of
which is enhanced by interaction with the Dnmt3L pro-
tein (5,6).Methylation patterns aremaintained by the hemi-
methylation specific DNAmethyltransferase Dnmt1. How-
ever, it is becoming increasingly clear that the maintenance
and regulation of DNAmethylation is much more dynamic
than initially anticipated (1,7,8).
To date, most DNA methylation studies have been de-
scriptive in nature and although they provide important sta-
tistical and correlative information about the distribution
of the DNA methylation mark in diverse cells and tissues,
they do not allow the study of the direct mechanistic princi-
ples governing the establishment of methylated or unmethy-
lated states at native genomic loci and their epigenetic con-
sequences. Synthetic epigenetics approaches on the other
hand provide means to precisely introduce or remove chro-
matin marks in the genome (9–11), therefore allowing the
study of causal interferences regarding the presence or ab-
sence of an epigenetic mark. These tools rely on a sequence
specific delivery of chromatin editors to genomic target loci,
thus forcing a change of the epigenetic state in the selected
region. To date, most of the targeted epigenetic tools have
relied on programmable C2H2 zinc fingers or TALE arrays
(reviewed in (9,11,12)), which have the disadvantage of the
need to re-design and re-construct the targeting domain for
each novel target sequence. The emergence of the bacte-
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rial Clustered Regularly Interspaced Short Palindromic Re-
peats (CRISPR) (13) system and the nuclease-inactivated
CRISPR variant (dCas9) as a programmable genome tar-
geting technology has opened new possibilities to target epi-
genetic effectors (14–16).
In this work, we show that targeting of an engi-
neered Dnmt3a–Dnmt3L single-chain DNA methyltrans-
ferase (Dnmt3a3L) fused to the nuclease-inactivated dCas9
leads to efficient and widespread DNAmethylation of CpG
islands located within targeted promoters (up to 1200 bp).
Targeted methylation with the Dnmt3a3L fusion protein is
∼4–5 times stronger than the methylation achieved through
targeting of Dnmt3a alone. Peaks of methylation are ob-
served around 25 bp upstream and 40 bp downstream of
the PAM site, while 20–30 bp of the dCas9 binding site it-
self are protected against methylation. In general, targeting
with single guide RNAs is sufficient for methylation and
multiplexing does not increase its efficiency. In addition,
using this system we illustrate that the multimerization of
theDnmt3a3L protein onDNA contributes to introduction
and spreading of DNA methylation within the targeted ge-
nomic region.
MATERIALS AND METHODS
Generation of Cas9-Dnmt3a–Dnmt3L –SC fusion construct
The M-SPn-Cas9-VP64 plasmid (Addgene plasmid
#48674) (17) was used as the base for the introduction of the
Dnmt3a–Dnmt3L single-chain construct (18). The vector
backbone was amplified using vector specific primers listed
in Supplementary Table S4. The murine Dnmt3a catalytic
domain was amplified from ZNF-Dnmt3a CD plasmid
and Dnmt3a CD fused to the Dnmt3L C-terminal domain
from the ZNF-Dnmt3a3L plasmids (18) with D3a Cas9 f,
D3a Cas9 r and D3a3L Cas9 f, D3a3L Cas9 r primers
using Q5® High-Fidelity DNA Polymerase (NEB). The
insert and the vector backbone were joined using Gibson
assembly (NEB). Proper sequence of the resulting clones
was confirmed with Sanger sequencing. The plasmid maps
are depicted in Supplementary Figure S2B).
Design of the guide RNAs for the EPCAM, CXCR4 and
TFRC promoters
The sequences of the promoter regions (containing the CpG
islands) of human EpCAM, CXCR4 and TFRC genes were
extracted using UCSC genome browser. Potential guide
RNA targeting sequences specific for these promoters were
identified using the E-CRISP server (19). For EpCAM, a se-
lection of twelve unique guide RNA binding sites was cho-
sen to cover the region with 100–200 bp in between the gR-
NAs (shown in Supplementary Table S3). For CXCR4 and
TFRC, four and ten gRNAs locations were selected, respec-
tively. Each of the guide RNA constructs was generated as
a separate gRNA plasmid. The gRNA plasmids were syn-
thesized using overlapping ssDNA oligonucleotides which
were cloned into the empty gRNA plasmid (Addgene plas-
mid # 41824) (20) using Gibson Assembly® Master Mix
(NEB) following the manufacturer protocol. All gRNA
constructs were validated with Sanger sequencing. Poten-
tial off-target binding sites for the gRNAs were predicted
using CRISPOR (http://crispor.tefor.net/crispor.py). Four
highest scoring off-target sites were selected based on the
MIT or CFD scores and primers for bisulfite sequencing
were designed directly surrounding these regions (primer se-
quences are provided in Supplementary Table S2).
Cell culture, transfections, MACS selection
The human ovary adenocarcinoma cell line, SKOV-3 (a
generous gift of Dr Marianne Rots) and HEK293 cells
were maintained at 37◦C with 5% CO2 in DMEM me-
dia supplemented with 10% FCS (Sigma-Aldrich), 1×
penicillin/streptomycin and 8 mM glutamine. For SKOV-
3 cells transfection, the cells were trypsinized and seeded
in six-well plates or T25 flasks at 40% density. The follow-
ing day, the cells were immersed in the transfection cock-
tail composed of 5% of a modified pVenus-NLS plasmid
(derived from Addgene #27794 plasmid) (21), 5% of the
pLNGFR plasmid (Miltenyi Biotec), 70–88% of individ-
ual or equimolar mixture of pooled gRNA plasmids and 2–
20%of SPn-Cas9-Dnmt3a3L-SC plasmid (% of total DNA,
2 or 4 g for six wells or T25s, respectively) containing 6
or 12 g PEI MAX MW 40 000 (Polysciences). The cells
were washed with Dulbecco’s PBS and immersed in nor-
mal cell media 14 h post-transfection. Subsequently, the
medium was exchanged every two days. Magnetic activated
cell sorting (MACS) was performed following the manu-
facturer’s instructions at fifth day post-transfection and the
sorted cells were frozen for further analysis. The percent-
age of the Venus positive cells before and afterMACS selec-
tion was quantified using fluorescence microscopy (EVOS)
and FACS analysis (BD FACS Calibur). Approximately 10
000 cells were analyzed for each sample. HEK293 cells were
maintained as described above and transfected using a sim-
ilar protocol, with the exception that 10% mVenus C1 and
no pLNGFR were used.
Bisulfite sequencing – DNA methylation analysis
Genomic DNA from frozen cells was extracted using QI-
Aamp DNA Mini Kit (Qiagen) and bisulfite converted
using EZ DNA Methylation-Lightning™ Kit (Zymo Re-
search) following manufacturer’s instructions. The bisulfite
treated DNAwas used for PCR amplification using the am-
plicon specific primers (listed in Supplementary Table S2)
and HotStarTaq DNA Polymerase (Qiagen), subsequently
purified and sub-cloned using StrataClone PCR Cloning
Kit (Agilent Technologies). Single positive colonies were
picked and sequenced with standard Sanger sequencing us-
ing vector specific primers.
NGS library preparation and high-throughput sequencing
For Illumina library preparation, genomic DNA was iso-
lated from each experimental samples using QIAampDNA
Mini Kit (Qiagen), bisulfite converted and the specific
amplified regions of the targeted promoters were cleaned
up with SPRI beads (Agencourt AMPure XP, Beckman-
Coulter). For each experimental sample, the separate am-
plicons covering the different investigated CpG islands were
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mixed in an equimolar ratio, end repaired and A-tailed us-
ing the components of the SureSelect (Agilent Technolo-
gies) library preparation kit. Subsequently, the mixed am-
plicons belonging to one experimental sample were ligated
to unique TruSeq HT double indexed adapters and cleaned
up with SPRI beads. The uniquely indexed DNA samples
were pooled and PCR amplified (eight amplification cycles)
using the Illumina specific primers, SPRI purified and quan-
tified withNEBNext Library quantification kit for Illumina
(NEB). Sequencing was performed on a MiSeq machine
with 2×300 PE run at the Microbiome Core Facility (UNC
School of Medicine, Chapel Hill, USA).
Bisulfite sequencing analysis
The high-throughput sequencing results were demulti-
plexed using Qiime package, subsequently quality filtered
and adapter trimmed with Trim Galore (v0.4.1, using
default parameters––Phred score: 20; Paired, http://www.
bioinformatics.babraham.ac.uk/projects/trim galore/),
mapped to the human genome (GRCh38) with Bismark
(v0.14.4; options –non directional) and further visualized
with SeqMonk (http://www.bioinformatics.babraham.ac.
uk/projects/seqmonk/). The methylation levels were deter-
mined for each CpG site within the regions of interest with
SeqMonk using the ’Difference quantification’ function
(as a percent of methylated CpGs calls over total calls
for each site) and retrieved using the ’Annotated probe
report’ function. Further visualization and analysis was
performed in MS Excel. In the figures, average methylation
per CpG site is provided or average methylation of a region
calculated as the mean of average methylation of all CpG
sites present in the reported region. At least a 1000-fold
coverage of the CpG sites was achieved. The methylation
profiles of the sub-cloned amplicons were analyzed with
BISMA (22) using default parameters. The BISMA results
are directly shown in Supplementary Figures S7 and S8.
RT-qPCR
RT-qPCR was performed on total RNA extracted from
frozen untransfected and transfected HEK293 and SKOV-
3 cells. For this, total RNA from frozen cells was ex-
tracted with RNeasy Mini Plus Kit (Qiagen) for HEK293
cells or Ambion PureLink RNA Mini kit (Life Technolo-
gies) for SKOV-3 cells and reverse transcribed (using oligo-
dT18-primers (NEB)) with M-MuLV Reverse Transcriptase
(NEB) while protected by RNasin plus (Promega). Quan-
titative PCR was performed with SsoFast EvaGreen Su-
permix on a CFX96 Connect Real-Time detection system
(both from Bio-Rad) with ACTB as a reference gene in
at least two biological replicates (each with three techni-
cal repeats) and analyzed using the Ct method. All the
primers used for quantification are listed in the Supplemen-
tary Table S1.
RESULTS
Design of the targeted methylation study
To take advantage of the targeting flexibility of the
CRISPR/dCas9 system, we fused the catalytic C-terminal
domain of the mouse Dnmt3a DNA methyltransferase
(MTase) or the Dnmt3a–Dnmt3L C-terminal domain
single-chain construct (18) to the nuclease-inactivated
dCas9 (23,24) (Figure 1A). These fusion proteins were em-
ployed to introduce DNA methylation at the unmethylated
CpG islands within the gene promoters of epithelial cell ad-
hesion molecule (EpCAM), transferrin receptor protein 1
(TFRC, also known as CD71) and C-X-C chemokine re-
ceptor type 4 (CXCR4). In order to achieve this, we tiled
the CpG islands of the target promoters with 12, 10 and 4
gRNAs binding sites, respectively, spaced 100–400 bp apart
(Figures 1B, C and 2A). Next, we transiently co-transfected
the dCas9-DNAMTase fusions along with single or pooled
gRNA constructs into HEK293 cells (TFRC and CXCR4)
or SKOV-3 cells (EpCAM). We obtained typical transfec-
tion efficiencies of around ∼80% for HEK293 and 30–40%
for SKOV-3 cells, for whichMACS selection was performed
to enrich the transfected cell population to ∼80% (Supple-
mentary Figure S1). Both dCas9-methyltransferase fusions
were efficiently expressed in the cells as illustrated by West-
ern blotting (Supplementary Figure S2A). The transfected
cells were cultured for 5 days, harvested and themethylation
levels in the selected promoters were determined by Sanger
or next-generation targeted bisulfite sequencing.
Control experiments showed that expression of gRNAs
alone did not cause any changes in the DNAmethylation at
the target promoters (Figures 1B, C, 2A and Supplemen-
tary Figures S3, S5, S7 and S9). Similarly, no significant
increase in DNA methylation was observed in the TFRC
or CXCR4 promoters after expression of the untargeted
dCas9–Dnmt3a3L construct. At the EpCAM promoter, a
slight increase in methylation from 6.4 ± 1.8% in untreated
SKOV-3 cells to 11.2 ± 0.1% after treatment (for details re-
fer to Supplementary Table S5) was detected predominantly
within the EpCAM gene body (Figure 2A and B).
Targeting the dCas9–Dnmt3a3L with single gRNAs leads to
efficient genomic methylation
Next, we targeted the dCas9–Dnmt3a3L fusion construct
to defined single sites within the analyzed promoters using
10 different gRNAs for TFRC (Figure 1B), 4 gRNAs for
CXCR4 (Figure 1C) and 12 gRNAs for EpCAM (Figure
2A). In contrast to the control experiments, co-transfection
of the gRNAs and dCas9–Dnmt3a3L plasmids caused in-
troduction of robust methylation at the targeted promot-
ers with most of the gRNAs. The strongest methylation of
the TFRC promoter was observed with gRNATFRC 3, 6 and
7, which resulted in 38.5 ± 2.2%, 35.1 ± 6.5% and 34.0 ±
2.6% average methylation, respectively (Supplementary Ta-
ble S5). The average methylation introduced by most of the
gRNATFRC ranged between 23.6 ± 1.9% and 30.3 ± 0.5%.
Co-transfection of dCas9–Dnmt3a3L with gRNATFRC 1,
which targets a site located ∼340 bp upstream of the am-
plicons used for bisulfite sequencing, resulted in 15.3 ±
1.1% average methylation (Figure 1B and D). gRNATFRC
10, which is located at the boundary of the CpG island
caused only 14.2 ± 1.4% methylation. Similarly, targeting
the CXCR4 promoter with gRNAsCXCR4 1, 2 or 3 resulted
in efficient methylation of the CpG island, reaching 28.3 ±
1.0%, 35.3 ± 1.8% and 31.2 ± 0.3% average methylation,
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Figure 1. The dCas9–Dnmt3a3L fusion protein deposits DNA methylation at endogenous human TFRC and CXCR4 promoters in HEK293 cells. (A)
Schematic structure of the dCas9–Dnmt3a3L and Dnmt3a CD fusion proteins. The catalytically inactive dCas9 gene was fused to an engineered Dnmt3a–
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respectively. gRNACXCR4 4, which binds to a site ∼370 bp
upstream of the bisulfite amplicons, caused introduction of
13.3 ± 1.5% methylation within the analyzed amplicons.
In the EpCAM promoter, targeting the dCas9–Dnmt3a3L
construct with the individual gRNAsEpCAM 1–3 or 5–10
triggered methylation between 25% (for gRNAEpCAM 9) to
33.7% (for gRNAEpCAM 2). gRNAEpCAM 11 and 12, which
are targeting the boundary of the CpG island, caused only
weak methylation, comparable to the methylation increase
observed with untargeted dCas9–Dnmt3a3L. Interestingly,
targeted methylation with gRNAEpCAM 4 in the EpCAM
promoter was less efficient than with other neighboring gR-
NAs, which might be explained by the fact that the gRNA
binding site overlaps with the annotated TSS, where the
transcriptional machinery could prevent stable binding of
the dCas9 fusion.
In summary, we conclude that single gRNAs co-
transfected with dCas9–Dnmt3a3L can cause robust DNA
methylation. Strikingly, although the depositedmethylation
was most prominent on the 3′ side next to the dCas9 tar-
geted sites, where based on modeling the fusion partner is
presented (reaching up to 60.5 ± 1% for gRNATFRC 3 or
49.1 ± 2.7% for gRNACXCR4 2), the DNA methylation sig-
nal was propagated over the entire promoter in most cases
(Figures 1B, C, 2A and Supplementary Figures S3, S5 and
S9).
Our data show that the efficiency of dCas9 mediated
targeted methylation is comparable to previous targeting
systems. For example, targeting the EpCAM promoter in
SKOV-3 cells Nunna et al. observed introduction of 29%
methylation in transient transfection experiment, whereas
in stably transfected cells 46–48%DNAmethylationwas de-
tected (albeit within a shorter analyzed region) (25).
Targeting multiple sites does not increase the DNA methyla-
tion levels
Subsequently, we tested whether co-targeting of the loci
with multiple gRNAs could further increase the methyla-
tion levels. However, targeting with all ten gRNAs to the
TFRC promoter did not result in increased methylation ef-
ficiency (28.3 ± 1.5%) when compared to single gRNA tar-
geting experiments (e.g. gRNATFRC 3––38.5 ± 2.2%). Sim-
ilarly, no significant enhancement of targeted methylation
was achieved at the CXCR4 promoter after co-targeting
with all four gRNAsCXCR4 (31.8 ± 0.4%), nor at the Ep-
CAM promoter co-targeted with gRNAEpCAM 6, 7, 9 and
10 (35.8 ± 2.3%) (Figures 1D, 2B). This may be caused by
a less efficient expression of gRNA transfected as pools or
by a competition of gRNAs for dCas9-DNA MTase pro-
teins, which finally prevents an increase in efficiency. Fu-
ture work will show if improved systems can be developed
to overcome these barriers. Importantly, the dCas9-fusions
targeting a catalytic mutant Dnmt3a3L C706A, which car-
ries an amino acid exchange in the catalytic center, could
not trigger DNAmethylation (Figures 1B, C, D and 2A, B),
showing that the catalytic activity of the targeted DNMT is
necessary for efficient DNA methylation.
Dnmt3a3L causes more efficient methylation at the target
promoters than Dnmt3a catalytic domain
In order to directly compare the efficiency of targeted
DNA methylation introduced by the dCas9–Dnmt3a-CD
and dCas9–Dnmt3a3L we targeted both MTase fusions
in parallel experiments to three separate loci. For this,
we have chosen the single gRNAs targeting EpCAM,
CXCR4 and TFRC promoters that showed the highest ef-
ficiency with dCas9–Dnmt3a3L.The results indicate that
Dnmt3a3L outperformed Dnmt3a CD (despite similar ex-
pression levels in the transfected cells (Supplementary Fig-
ure S2A)) in all three experiments, with 3.8× (gRNAEpCAM
5), 4.9× (gRNACXCR4 2) and 4.6× (gRNATFRC 3) higher
methylation efficiency (Figure 3A and B).
Distribution of DNA methylation levels and spreading of
methylation
Comparison of all data shows highest methylation right up-
stream of the PAM site (around +25 bp). A second (weaker)
peak of methylation is observed downstream of the PAM
site (around –40 bp). These maximamay represent the foot-
print of the bound dCas9-DNA MTase fusion protein and
indicate the nearest free DNA available for binding of the
methyltransferase. The fact that DNA methylation is not
introduced directly at the dCas9 binding sites suggests that
dCas9 occupancy protects the overlapping CpG sites from
methylation by the DNAmethyltransferase (Figure 4). The
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Dnmt3L C-terminal domain single-chain construct or Dnmt3a C-terminal domain with a 28 amino acid linker (containing NLS peptide). An additional
NLS was added at the C-termini of both constructs. The residues that were mutated in this study within the catalytic domain of Dnmt3a in both Dnmt3a
CD and Dnmt3a3L proteins are indicated (C706A inactivates the methyltransferase and R832E disrupts the multimerization of Dnmt3a). Not drawn to
scale. (B) Genomic region of the human TFRC promoter that was targeted with the dCas9 fusions (Chr. 3: 196081310–196082794). Regions analyzed by
bisulfite sequencing are indicated with green bars. The location and directionality of the Cas9 target sites are shown by red arrow heads. The black vertical
lines indicate CpG sites. The gray bar denotes the 5′ UTR and the dotted line represents an intron. The heat map shows average methylation per CpG
site. Rows represent separate HEK293 co-transfection experiments where targeted methylation was induced with single or pooled gRNAs targeting the
annotated region, columns represent separate CpG sites in the investigated region. Direction of the transcription is indicated with black arrow above the
gene name. (C) Targeted methylation of the CXCR4 promoter in HEK293 cells (Chr.2: 136116618–136117805) illustrated as described in (B). The heat
map shows acquisition of DNA methylation in the CXCR4 promoter region when targeting the dCas9–Dnmt3a3L with single or pooled gRNAs. (D)
Average DNAmethylation over all CpG sites within the analyzed regions in the HEK293 cells that were co-transfected with single or pools of gRNA. The
analyzed TFRC and CXCR4 regions comprise 118 and 101 CpG sites respectively. The error bars denote STDEV from methylation averages measured
in two biological samples. Color of the bars denotes experimental sets: green––control experiments, light blue––targeting of the dCas9 fusions with single
gRNAs, dark blue––targeting with multiple gRNAs and yellow corresponds to targeting of C706A catalytic mutant. (E) Relative mRNA expression of
TFRC and CXCR4 in the cells co-transfected with dCas9–Dnmt3a3L and single or pools of gRNAs as determined by RT-qPCR (error bars represent
SEM from at least two biological replicates performed in technical triplicate). *P < 0.05, **P < 0.0001, unpaired t-test relative to ’gRNA only’ control
experiment.
 at Edinburgh U
niversity on D
ecem
ber 5, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
6 Nucleic Acids Research, 2016
0
0.2
0.4
0.6
0.8
1
1.2
SK
O
V
-3 2 5 7 10
6 
+ 
7 
+ 
9 
+ 
10
6 
+ 
7 
+ 
9 
+ 
10
Ep
CA
M
/β
-a
ct
in
1
2
3 4 5 6 7 8 9 10 11 12
12
6,7,9,10
1-12
SKOV-3
6,7,9,10
C706A
1
2
3
4
5
6
7
8
9
10
11
dC
as
9-
D
nm
t3
a3
L
None
80%
0%
40%
dCas9-Dnmt3a3L wt
A
B
C7
06
A
1 2 3 4 5 6 7 8 9 10 11 12
EpCAM
CpG sites
0
5
10
15
20
25
30
35
40
SK
O
V
-3 A
ll
N
on
e 1 2 3 4 5 6 7 8 9 10 11 12
6 
+ 
7 
+ 
9 
+ 
10
6 
+ 
7 
+ 
9 
+ 
10
A
ve
ra
ge
 m
et
hy
la
ti
on
 [%
]
dCas9-Dnmt3a3L wt
C7
06
A
C
*
***
*
**
**
Figure 2. Targeted methylation of the endogenous human EpCAM promoter in SKOV-3 cells with dCas9–Dnmt3a3L. (A) The dCas9–Dnmt3a3L fusion
protein was targeted either to separate or multiple sites within the CpG island in the EpCAM promoter (Chr. 2: 47368894–47370157). Methylation was
investigated in four consecutive amplicons covering the CpG island (indicated with green bars). For details cf. the legend to Fig. 1B. The heat map shows
targetedDNAmethylationwithin the EpCAMpromoter CpG islandwhen the dCas9–Dnmt3a3L fusion protein was targeted to single ormultiple locations
within the island. (B) Average methylation level observed over the whole analyzed EpCAM promoter region containing 131 CpG sites. The guide RNAs
that were used in the targeting experiments are indicated. Error bars represent SEM of average methylation from two biological replicates. Color of the bars
denotes experimental sets: green––control experiments, light blue––targeting of the dCas9 fusions with single gRNAs, dark blue––targeting with multiple
gRNAs and yellow corresponds to targeting of C706A catalytic mutant. (C) Relative EpCAM mRNA expression levels measured with RT-qPCR. The
numbers below the bars denote gRNAs that were used to target the dCas9–Dnmt3a3L. The error-bars denote SEM from at least two biological repeats
performed in technical triplicate). *P < 0.05, **P < 0.0001, unpaired t-test relative to ’SKOV-3’ control experiment.
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profiles also present interesting additional peaks of methy-
lation ∼200 bp upstream and downstream of the PAM site.
This finding may suggest that the region in between is par-
tially blocked by nucleosomes and the bound MTase most
efficiently reaches the next available linker DNA region.
Similar spreading ofDNAmethylationwas also observed in
other targeted methylation studies using zinc fingers (26,27)
and TALE effectors (28).
Specificity of targeted DNA methylation
Having shown the efficient methylation of the target sites,
the question appeared if off-target DNA methylation is in-
troduced at additional genomic locations. To check this, we
have predicted off-target gRNAbinding sites for four of our
most efficient gRNAs and analyzed the methylation status
of these off-target loci and determined methylation at unre-
lated CpG islands and using untargeted dCas9-MTase con-
structs. Out of four analyzed off-targets, two showed a mild
methylation increase (9.2% and 11.1% increase of methyla-
tion at the off-targets compared to 25.6% and 34.7% at the
targets using gRNATFRC 2 and 3, respectively). The other
two regions were already fully methylated in the untreated
cells hence non-informative (Supplementary Figure S11A,
B). Moreover, untargeted dCas9–Dnmt3a3L did not cause
methylation of the TFRC, CXCR4 or EpCAM promoters,
nor four additional unrelated CpG islands which do not
contain sequences resembling the gRNA target sites (Sup-
plementary Figure S11C).
Targeted DNA methylation causes gene repression
DNA methylation of CpG rich promoters is associated
with repression of gene expression; therefore, we investi-
gated whether the introduced DNA methylation is capa-
ble of silencing expression of the associated genes. Indeed,
when targeting the TFRC promoter with gRNATFRC 2 or
3 that caused the most efficient DNA methylation, we ob-
serve roughly 50% repression of TFRC expression. Simi-
larly, targeting the CXCR4 promoter with gRNACXCR4 3
also decreased the gene expression to 58 ± 3% (Figures 1E
and 2C). When interpreting these numbers it must be kept
in mind, that transient experiments were conducted with
transfection yields around 80%.When targeting the inactive
Dnmt3a3L (C706A R832E) mutant with the same gRNAs,
we also observed a smaller decrease in the expression of the
target genes to 78 ± 3% with gRNATFRC 2 and 81 ± 4%
for gRNACXCR4 3. This can be explained by the binding of
the dCas9 protein, which can inhibit transcriptional elonga-
tion by blocking the passage of the RNA polymerase (29),
steric clashes with binding of transcription factors or com-
ponents of the preinitiation complex. This suggests that the
observed transcriptional silencing is caused by introduced
DNA methylation, but partially also by the strong binding
of dCas9 that interferes with transcription.
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Figure 4. Relative distribution of targeted DNA methylation. Scatter plot showing the average gain of DNA methylation at all CpG sites observed at the
EpCAM, TFRC and CXCR4 promoters with single guide RNAs targeting dCas9–Dnmt3a3L. The location of the CpG sites relative to the targeted dCas9
sites is indicated on the X axis. Each dot represents the average methylation gain (Y axis) of a specific CpG site in one of the targeting experiment corrected
for the DNAmethylation present at that site in untreated cells. The blue line represents the mean methylation level measured in a sliding window of 15 bp.
The guide RNA binding site and orientation are depicted as a red arrow. Upper and lower panels show regions between –100 bp to 100 bp and –400 bp to
400 bp from the PAM site, respectively.
Mechanism of targeted DNA methylation
As described above, targeting of the dCas9–Dnmt3a3L
construct resulted in robust methylation across the entire
EpCAM, CXCR4 and TFRC promoters, with methyla-
tion observed as far as 1 kb away from the gRNA bind-
ing site. The cooperative multimerization of Dnmt3a and
Dnmt3a/Dnmt3L complexes along the DNA has been re-
ported in vitro with purified recombinant proteins (30,31)
and this process was shown to contribute to the efficient
methylation of DNA in vitro (32). To test if the multimer-
ization of Dnmt3a has a role in targeted DNA methylation
in cells, we targeted the Dnmt3a mutants which affect the
catalytic center (C706A), or disrupt the polymerization in-
terface (R832E) (31) or both (C706A R832E). It should be
noted that the R832E mutation, in agreement with the role
of multimerization for DNAmethylation activity, decreases
the catalytic activity of Dnmt3a by ∼2-fold in vitro (31).
Next, we compared the methylation patterns of the inves-
tigated promoters upon targeting the wild type or mutant
dCas9–Dnmt3a3L fusion proteins. The wild type dCas9–
Dnmt3a3L caused strong and widespread methylation over
the entire CpG island of the EpCAMpromoter (Figure 5A)
when co-targeted to four sites (gRNAEpCAM 6, 7, 9 and
10). The R832E mutant, however, introduced less methy-
lation that was confined to the nearest vicinity of the tar-
geted sites (between 10 and 50 bp away from the binding
sites), while the C706A and the double C706A/R832E mu-
tants did not methylate the locus at all (Figures 1, 2 and 5).
Similar results were obtained in the analyses of the CXCR4
and TFRC promoters (Supplementary Figure S4 and S6).
Interestingly, with the dCas9–Dnmt3a3L R832E mutant
we also observed weak methylation on remote well-defined
sites (denoted with * in Supplementary Figure S10A). How-
ever, no efficient DNAmethylation spreading was observed
for the R832E mutant, showing that the lateral multimer-
ization of the Dnmt3a/Dnmt3L complex contributes to the
establishment of DNAmethylation at the targeted sites and
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Figure 5. Spreading of DNA methylation is dependent on Dnmt3a3L multimerization. (A) Heat map of DNA methylation deposited within the EpCAM
promoter region in untransfected SKOV-3 cells and cells co-transfected with a pool of guide RNAs (EpCAM gRNAs 6, 7, 9 and 10) and the dCas9–
Dnmt3a3L wild type, catalytically inactive mutant C706A, non-multimerizing R832E mutant or a C706A R832E double mutant. (B) Model illustrating
the mechanism of DNA methylation setting and spreading. Binding of the effector domain of targeted dCas9–Dnmt3a3L can be achieved both in cis and
in trans relative to the DNA strand bound by dCas9 (here shown for two different guide RNAs). This leads to the deposition of DNA methylation (black
filled circles) in the direct vicinity of the bound site or on a DNA strand that comes into spatial proximity to the dCas9 bound site. The Dnmt3a3L dimers
can multimerize along the DNA via the R832 interaction interface (top). The R832Emutant with a disrupted multimerization interface cannot form fibers,
leading to more locally defined DNA methylation either directly next to the dCas9 binding site or further away via DNA looping (middle). In a native
situation (bottom), a transcription factor (brown) can recruit native Dnmt3a (green) or in complex with Dnmt3L (blue) to a specific site; this in turn can
serve as a nucleation point to elongate the formed fiber causing cooperative deposition of DNA methylation in a larger genomic region.
in larger regions of the genome.Moreover, the lack of strong
introduced DNA methylation for the C706A mutant in-
dicates that the fusion protein does not recruit the native
Dnmt3a,Dnmt3b andDnmt3Lmachinery, presumably due
to the low expression levels of the endogenous Dnmt3 en-
zymes in the cell lines used here. Collectively, these data sug-
gest that themultimerization of theDnmt3a/Dnmt3L com-
plexes on the DNA is a mechanism which allows efficient
methylation and spreading of DNA methylation across a
selected genomic region upon targeting of the Dnmt3a/3L
complex, for example by a transcription factor (Figure 5B).
DISCUSSION
In this study, we show that the CRISPR/Cas9 pro-
grammable genome targeting system can be successfully
employed to introduce DNA methylation at defined en-
dogenous genomic loci, leading to transcriptional silenc-
ing. We further show that efficient methylation of an en-
tire CpG island can be achieved by targeting the Dnmt3a3L
fusion construct to a single site within the island. Notably,
DNAmethylation is most efficiently deposited directly next
to dCas9 binding sites; nevertheless, we observe efficient
DNA methylation across the entire CpG islands (up to
1000 bp away from the target site). We detected a mild
methylation increase (9.2% and 11.1%) at two of the pre-
dicted, highest scoring off-target regions, which was sig-
nificantly weaker than the methylation at the correspond-
ing on-target sites for the used gRNAs (25.6% and 34.7%).
In addition, untargeted dCas9–Dnmt3a3L did not cause
methylation of the CXCR4, TFRC promoters nor of four
unrelatedCpG islands.We speculate that the observedweak
off-target methylation at near-cognate binding sites could
be attributed to transient dCas9 binding at these sites, thus
allowing a time window for DNA methylation deposition.
Highly specific Cas9 mutants developed recently (33,34)
could be used to increase the specificity of targeted DNA
methylation in cells. Alternatively, the expression level of
the dCas9 fusion proteins could be reduced to increase the
specificity of target occupancy.
Furthermore, our results indicate that the efficientmethy-
lation and spreading could be attributed to the multimer-
ization of Dnmt3a/Dnmt3L complexes on the DNA, as
illustrated by the fact that less methylation and no effi-
cient spreading was observed when we targeted the non-
multimerizingR832Emutant ofDnmt3a3L. This illustrates
for the first time the role of Dnmt3a3L multimerization in
the establishment and spreading of targeted de novo DNA
methylation in cells. Mechanistically, this finding can be
explained by a model considering a multistep pathway fi-
nally leading to efficient DNA methylation at the target
site that is initiated by a diffusional encounter of the teth-
ered MTase with a substrate DNA site. The ability to mul-
timerize increases the DNA binding strength of Dnmt3a,
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which raises the probability that a transientDNAencounter
leads to the formation of a stable Dnmt3a3L–DNA com-
plex followed by DNA methylation. Notably, formation of
a long Dnmt3a3L fiber that would cover the whole CpG
island (∼1000 bp) is rather unlikely, as this would cause a
larger distortion of the local chromatin structure, including
displacement of nucleosomes. However, we envision a dy-
namic formation of shorter multimers that would cause lo-
cal methylation of the bound DNA. Methylation of remote
regions within the locus could be achieved through DNA
looping and subsequent multimer formation and methyla-
tion at the distant site. As the propensity of a diffusional
encounter of the tethered enzyme and DNA declines with
the distance of the DNA site to the targeted region, efficient
binding of the tethered MTase to remote DNA sites is even
more dependent on the ability of Dnmt3a tomultimerize on
DNA.
We show here the targeted methylation of larger DNA
regions by dCas–Dnmt3a3L. This approach mimics estab-
lishment of natural DNA methylation patterns and it in-
creases the probability of causing a strong biological re-
sponse (as for example changes in gene expression as shown
here). Additionally, we observed that the CpG sites that are
covered by the bound dCas9 protein are almost completely
protected from DNA methylation, illustrating that inacti-
vatedCas9 stays firmly bound to its target site. This explains
why dCas9 alone can be used to out-compete and displace
DNA binding proteins (such as transcription factors) to di-
rectly affect transcription, as observed by others (24). In a
more general view, it suggests that targeting of dCas9 to
sites bound by other protein factors can be applied in or-
der to investigate their functions at a specific genomic site.
The pattern of the targeted DNAmethylation suggests that
Dnmt3a preferentially methylates linker DNA, which is in
agreement with earlier in vitro data and cellular methylation
studies (35–39).
Targeting of our epigenetic editing tools based on DNA
methyltransferase domains caused down-regulation of gene
expression at three different promoters tested, indicating
that it could be used as a universal tool for gene repression.
Alternative tools, like CRISPRi or based on the targeted
recruitment of transcriptional repressors (like for example
KRAB domain) have been developed and successfully used
to down-regulate gene expression as well (14,24,29). The
possible advantage of targeted methylation is that it has the
potential of causing durable effects. Future work will show
which of these techniques finally will prove most useful for
targeted gene regulation.
During preparation of this manuscript, dCas9 targeted
DNAmethylation was described by two other groups using
dCas9 fused to the catalytic domain of Dnmt3a (40,41). Vo-
jta and colleagues observed efficient targeted methylation
occurring in a distance of∼35 bp downstream of the dCas9
binding sites, which is consistent with our findings. How-
ever, in contrast to the dCas9–Dnmt3a3L targeting used
here, co-targeting of multiple locations within the BACH2
promoter was required to achieve methylation of a wider
region (40). Similarly, McDonald et al. reported success-
ful targeted methylation using dCas9–Dnmt3a CD of the
CDKN2A, Cdkn1a and ARF promoters (41).
We envision that our dCas9–Dnmt3a3L programmable
DNA methylation writer will find numerous applications
in establishing the functional significance of DNA methy-
lation in gene repression and the control of the cellular dif-
ferentiation state, as well as to dissect the principles of net-
work responses to epigenetic changes in synthetic biology
settings. Moreover, targeted DNA methylation offers the
unique potential to correct epimutations in disease states.
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